Multidisciplinary collaboration is crucial for rheumatologist Laura Cappelli. Her recent study, conducted with Johns Hopkins oncologists, showed that patients with both an rheumatic disease and lung cancer who were diagnosed earlier had ...
Occasionally, patients with scleroderma also have or develop skeletal myopathies. Rheumatologist Julie Paik explains her recent study findings that these comorbidities lead to increase disease burdens and morbidity.
Gastrointestinal symptoms are common in people with systemic sclerosis. Rheumatologist Zsuzsanna McMahan shares her finding of a relationship between an antibody that may contribute to issues in the gastrointestinal tract in systemic sclerosis patients.
Immunotherapies are often effective when treating autoimmune disease and cancer but often lead to impaired immune function.
Rheumatologist Andrea Fava has identified accurate, noninvasive biomarkers found in urine that can be used to better diagnose and guide treatment for lupus nephritis.
Rheumatology fellow Rachel Wallwork discusses her latest research results on how an antibody in systemic sclerosis patients with cancer may be a key biomarker to predict possible cancer development.
Johns Hopkins geriatrician Nancy Schoenborn discusses her research regarding cancer screening decisions for older adults and the importance of considering each patient’s health status, life expectancy and preferences when deciding if and ...
Geriatrician Thomas Cudjoe discusses the relationship between social isolation and inflammatory biomarkers. Findings from a large nationally represented study indicate that social isolation has biological influences and could lead to poor health outcomes.
Vascular surgeon Christopher Abularrage, M.D. discusses recent research pertaining to diabetic foot wounds and best practices.
Curtiland Deville, MD, compares photon and proton treatment options in lung and sarcoma cases.
Finding ways to make cancer cells unable to spread, and ways to make other organs less fertile for cancer to take root.
Dr. Stephanie Terezakis and her research team are looking for ways to deliver radiation more precisely to tumors and minimize radiation to healthy tissues.
Dr. Alexander Pantelyat and his team collect blood and spinal fluid for genetic and proteomic analyses by using novel brain imaging techniques to distinguish between types of Parkinson’s-plus syndromes.
Johns Hopkins researchers have identified the genes responsible for aortic ballooning and the sequence of events leading to aortic aneurysms.
Dr. Mollie Meffert and her team investigate how genes and electrical flow interact to strengthen connections between neurons.
Dr. Errol Bush and his team are developing a “lung-in-box” program to strengthen donor lungs before transplantation. Their goal is to ensure high quality of life for recipients.
#TomorrowsDiscoveries: Andrew Cameron, a liver transplant surgeon, recognizes that many people wait on the transplant list. He and his team worked with Facebook to allow people to show their friends they are registered organ donors.
Dr. Elisseeff and her team are designing scaffolds to help our bodies heal themselves after injury. Discover more at: http://www.hopkinsmedicine.org/resear...
#TomorrowsDiscoveries: Dermatologist Luis Garza is working to reactivate the codes that allowed our cells to build our organs. Harnessing this code as adults could change typical healing from scarring to regeneration.
Cell biologist Andrew Ewald and his team have discovered what allows breast cancer cells to leave the main tumor and build new tumors in the lungs, bones and brains. Now, their goal is to identify patients whose breast cancer is likely ...
Neuroscientist Christopher Potter and his team understand that mosquitoes pass on a disease through a simple bite. They are working to understand how an insect’s brain interprets and responds to odors.
#TomorrowsDiscoveries: Dr. Cole and his team are developing chemical techniques to block the action of disease-causing genes. They plan to use these techniques to develop new therapies.
Many patients worry about not being able to get their eye drops into their eyes. They may miss their eyes with squeeze bottles, or in some cases scratch their eyes.
#TomorrowsDiscoveries: Dr. DeWeese and his team are testing a way to target a protein found on the surface of cancer cells, but not non-cancer cells. Their goal is to destroy cancer while protecting normal tissue.
#TomorrowsDiscoveries: How does eating too much sugar lead to health problems? Dr. Hart explains the connection between dietary sugar and a unique sugar in our bodies that alters proteins’ function in response to nutrients and glucose.
#TomorrowsDiscoveries: Heart failure means that the heart is unable to pump enough blood, while heart arrhythmias occur when the heart’s electrical system is disorganized. Dr. Anderson and his team want to understand why heart failure ...
#TomorrowsDiscoveries: Mitochondria are the powerhouses of the cell, producing the energy we need to live. So it’s no surprise that problems with mitochondria have severe effects on the body. One of these is Barth Syndrome, a failure of ...
#TomorrowsDiscoveries: Normal brain tissue must be protected while doctors destroy a brain tumor. Researchers at Johns Hopkins are creating new, targeted treatments for brain tumor patients.
Can a custom-built white blood cell avoid suppression by cancer and boost our immune system? Dr. Jonathan Schneck has developed “artificial antigen-presenting cells” and is working to put them to use in the clinic.
Dr. Hans Bjornsson studies proteins bound to our DNA to find causes and potential treatments for a disease called Kabuki syndrome. His work may lead to one of the first treatments for an inborn intellectual disability.
Dr. Dan Arking explores the links between the number of energy-producing mitochondria in human blood cells, genetics and frailty.
Dr. Assaf Gilad is developing new technologies to “tag” stem cells and monitor cell fate with MRI, improving patient safety and treatment outcomes, especially for those with brain cancer and heart disease.
Dr. Gregg Semenza’s team has identified a way to overcome the resistance of cancer stem cells to chemotherapy, completely eradicating breast tumors in mice.
Dr. Elias Zambidis cares for children suffering from leukemia and other blood disorders.
Urologic oncologist Kenneth Pienta and his team are working to identify what keeps disseminated tumor cells asleep or reactivates them so that they can better treat prostate cancer.